1. Home
  2. DV vs VIR Comparison

DV vs VIR Comparison

Compare DV & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$11.45

Market Cap

1.6B

Sector

Technology

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.42

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DV
VIR
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DV
VIR
Price
$11.45
$9.42
Analyst Decision
Buy
Strong Buy
Analyst Count
15
7
Target Price
$16.37
$19.43
AVG Volume (30 Days)
3.2M
2.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
0.04
N/A
Revenue
$748,291,000.00
$68,556,000.00
Revenue This Year
$12.68
$270.22
Revenue Next Year
$9.75
N/A
P/E Ratio
$295.88
N/A
Revenue Growth
13.92
N/A
52 Week Low
$7.61
$4.16
52 Week High
$16.82
$11.66

Technical Indicators

Market Signals
Indicator
DV
VIR
Relative Strength Index (RSI) 55.38 46.20
Support Level $10.76 $8.40
Resistance Level $11.58 $10.33
Average True Range (ATR) 0.42 0.48
MACD 0.01 -0.10
Stochastic Oscillator 55.29 20.21

Price Performance

Historical Comparison
DV
VIR

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a media effectiveness platform that leverages artificial intelligence (AI) to drive superior outcomes for international brands by creating transparent ad transactions. Its solutions provide unbiased data analytics to improve the effectiveness, quality and return on advertising investments. DV Authentic Ad is its proprietary metric measuring whether an ad was delivered in a brand suitable environment, fully viewable, by a real person and in geography, while DV Pinnacle delivers these metrics in real time. The Company's solutions are integrated across programmatic platforms, social media channels and digital publishers, and are accredited by the Media Rating Council for digital ad measurement. It operates in the United States and international markets.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: